Seeing Is Believing
CADL is currently covered by 2 analysts with an average price target of $12.31. This is a potential upside of $7.5 (155.93%) from yesterday's end of day stock price of $4.81.
Candel Therapeutics's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of CADL is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 6.67% with an average time for these price targets to be met of 31.33 days.
Highest price target for CADL is $19, Lowest price target is $19, average price target is $11.
Most recent stock forecast was given by VERNON BERNARDINO from HC WAINWRIGHT on 10-Apr-2025. First documented stock forecast 22-Aug-2021.
Currently out of the existing stock ratings of CADL, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$19
$14.19 (295.01%)
$19
1 months ago
(10-Apr-2025)
1/5 (20%)
$14.03 (282.29%)
94
Buy
$3
$1.3 (76.47%)
$18
1 years 11 months 26 days ago
(15-May-2023)
0/2 (0%)
$1.4 (87.50%)
Buy
2 years 1 months 10 days ago
(30-Mar-2023)
0/1 (0%)
$7.07 (89.16%)
What is CADL (Candel Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CADL (Candel Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CADL (Candel Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CADL (Candel Therapeutics)?
Which analyst is the currently most bullish on CADL (Candel Therapeutics)?
Which analyst is the currently most reserved on CADL (Candel Therapeutics)?